XML 70 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1
(Schedule of Sundry Income (Expense), net) (Details) - USD ($)
$ in Millions
1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2017
Aug. 31, 2017
Sep. 30, 2016
Aug. 31, 2017
Sep. 30, 2016
Successor          
Component of Other Income [Line Items]          
Royalty income $ 9        
Net exchange gains (losses) 77        
Sundry Income (Expense) - Net 88        
Successor | Other Income [Member]          
Component of Other Income [Line Items]          
Interest income 12        
Equity in (losses) earnings of affiliates - net (4)        
Net gain on sales of businesses and other assets 1        
Net exchange gains (losses) 77        
Miscellaneous income and expenses - net [1] 2        
Sundry Income (Expense) - Net $ 88        
Predecessor          
Component of Other Income [Line Items]          
Net exchange gains (losses)   $ (195) $ (76) $ (394) $ (212)
Sundry Income (Expense) - Net   (112) (15) 166 407
Predecessor | Other Income [Member]          
Component of Other Income [Line Items]          
Royalty income [2]   11 27 84 108
Interest income   26 30 83 71
Equity in (losses) earnings of affiliates - net   13 22 55 60
Net gain on sales of businesses and other assets   2 0 205 [3] 384 [4]
Net exchange gains (losses)   (195) (76) (394) (212)
Miscellaneous income and expenses - net [1]   31 (18) 133 (4)
Sundry Income (Expense) - Net   $ (112) $ (15) 166 407
Predecessor | Food Safety Diagnostic Business [Member]          
Component of Other Income [Line Items]          
Pre-tax Gain on Disposal       162  
Gain on Disposal, Net of tax       $ 86  
Predecessor | Ownership interest in DuPont (Shenzhen) Manufacturing Limited [Member]          
Component of Other Income [Line Items]          
Gain on sale of entity         369
Gain on sale of entity, after-tax         $ 214
[1] Miscellaneous income and expenses - net, includes interest items, gains (losses) on available for sale securities, gains related to litigation settlements, licensing income, gains on purchases, and other items.
[2] In the Successor period, royalty income of $9 million is included in Net Sales.
[3] Includes a pre-tax gain of $162 million ($86 million net of tax) for the period January 1 through August 31, 2017 related to the sale of the global food safety diagnostic business. See Note 4 for additional information.
[4] Includes a pre-tax gain of $369 million ($214 million net of tax) for the nine months ended September 30, 2016 related to the sale of DuPont (Shenzhen) Manufacturing Limited. See Note 4 for additional information.